Neonatal respiratory distress syndrome (RDS) remains a leading cause of morbidity and mortality in preterm infants. This condition stems primarily from an insufficiency in pulmonary surfactant, a ...
Please provide your email address to receive an email when new articles are posted on . Minimally invasive surfactant therapy did not lower mortality among preterm infants with respiratory distress ...
The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement for TLI intellectual property covering a synthetic lung surfactant ...
Newborns who lack natural surfactants develop respiratory distress syndrome. Surfactants are materials that reduce liquid surface tension, enabling carbon dioxide and oxygen to easily exchange as ...
A research team analyzed the fundamental properties and structures of the naturally occurring substances that help human lungs expand and contract, providing insight into how the substances help us ...
The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement for TLI intellectual property covering a synthetic lung surfactant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results